148 related articles for article (PubMed ID: 381203)
1. Immunotherapy of guinea pig line 10 hepatoma with nonliving BCG cells in aqueous medium.
Bekierkunst A; Goren MB
Infect Immun; 1979 Jun; 24(3):817-20. PubMed ID: 381203
[TBL] [Abstract][Full Text] [Related]
2. Regression of a transplanted guinea pig hepatoma after intralesional injection of an emulsified mixture of endotoxin and mycobacterial sulfolipid.
Yarkoni E; Goren MB; Rapp HJ
Infect Immun; 1979 May; 24(2):357-62. PubMed ID: 378852
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls.
Yarkoni E; Rapp HJ
Infect Immun; 1979 Sep; 25(3):1087-9. PubMed ID: 387592
[TBL] [Abstract][Full Text] [Related]
4. Tumor regression caused by endotoxins and mycobacterial fractions.
Ribi EE; Granger DL; Milner KC; Strain SM
J Natl Cancer Inst; 1975 Nov; 55(5):1253-7. PubMed ID: 173865
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic trials of murine and guinea-pig solid tumors by oral administration of BCG.
Tokunaga T; Taguchi S; Chino F; Murohashi T
Jpn J Med Sci Biol; 1979 Feb; 32(1):1-18. PubMed ID: 470220
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
Yarkoni E; Rapp HJ
Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations.
Bartlett GL; Kreider JW; Purnell DM; Katsilas DC
Cancer; 1980 Aug; 46(3):488-96. PubMed ID: 6994867
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
[TBL] [Abstract][Full Text] [Related]
9. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
[No Abstract] [Full Text] [Related]
10. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
Minden P; Mathews HL
Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
[TBL] [Abstract][Full Text] [Related]
11. [Shared antigens between BCG and tumor cells--immunotherapy with BCG for mouse tumor].
Sasaki J; Kanda S; Sawamura D; Kamiya S; Inaba Y; Kawashima M
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1432-9. PubMed ID: 4015119
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic effectiveness of BCG inactivated by various modalities.
Kreider JW; Bartlett GL; Purnell DM
Cancer; 1980 Aug; 46(3):480-7. PubMed ID: 7397622
[TBL] [Abstract][Full Text] [Related]
13. Therapy of spontaneous metastases with an autologous tumor vaccine in a guinea pig model.
Hoover HC; Peters LC; Brandhorst JS; Hanna MG
J Surg Res; 1981 Apr; 30(4):409-15. PubMed ID: 7230788
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of guinea pig hepatoma.
Zbar B; Hunter J; Rapp HJ; Canti G
Cancer; 1979 Feb; 43(2):484-91. PubMed ID: 421175
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
Yarkoni E; Rapp HJ
Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
[TBL] [Abstract][Full Text] [Related]
16. Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.
Yarkoni E; Rapp HJ
Infect Immun; 1981 Jan; 31(1):514-6. PubMed ID: 7216457
[TBL] [Abstract][Full Text] [Related]
17. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery.
Hanna MG; Peters LC
Cancer; 1978 Dec; 42(6):2613-25. PubMed ID: 728864
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of a guinea pig hepatoma with living BCG: a frozen liquid and a lyophilized preparation are equally active.
Zbar B; Ribi E; Rapp HJ
Cancer; 1977 Dec; 40(6):2930-2. PubMed ID: 201359
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of a guinea pig hepatoma with mycobacterial vaccines: comparison of BCG cell walls and cell wall skeletons.
Yarkoni E; Rapp HJ
Infect Immun; 1978 Sep; 21(3):1029-32. PubMed ID: 361572
[TBL] [Abstract][Full Text] [Related]
20. A specific vaccine effective against stage I and stage II malignant disease in guinea pigs. Effect of variations in preparations and storage.
Yarkoni E; Hunter JT; Sukumar S
Cancer Immunol Immunother; 1982; 14(2):92-5. PubMed ID: 6965232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
